XTX Topco Ltd raised its stake in shares of Perrigo Company plc (NYSE:PRGO – Free Report) by 536.9% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 62,509 shares of the company’s stock after purchasing an additional 52,695 shares during the period. XTX Topco Ltd’s holdings in Perrigo were worth $1,640,000 at the end of the most recent quarter.
Other institutional investors have also modified their holdings of the company. Venturi Wealth Management LLC purchased a new position in Perrigo in the 3rd quarter valued at about $56,000. KBC Group NV raised its holdings in shares of Perrigo by 25.1% during the third quarter. KBC Group NV now owns 4,517 shares of the company’s stock valued at $118,000 after acquiring an additional 905 shares during the last quarter. Voisard Asset Management Group Inc. lifted its position in shares of Perrigo by 520.0% in the second quarter. Voisard Asset Management Group Inc. now owns 4,650 shares of the company’s stock valued at $119,000 after acquiring an additional 3,900 shares in the last quarter. Atria Investments Inc acquired a new stake in shares of Perrigo in the third quarter worth approximately $208,000. Finally, CWM LLC increased its position in shares of Perrigo by 877.0% during the second quarter. CWM LLC now owns 8,197 shares of the company’s stock worth $210,000 after purchasing an additional 7,358 shares in the last quarter. Institutional investors and hedge funds own 95.91% of the company’s stock.
Perrigo Stock Performance
NYSE PRGO opened at $28.07 on Friday. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.77 and a current ratio of 2.56. The stock’s fifty day moving average is $26.30 and its two-hundred day moving average is $26.99. The firm has a market capitalization of $3.83 billion, a P/E ratio of -23.99 and a beta of 0.52. Perrigo Company plc has a fifty-two week low of $23.89 and a fifty-two week high of $34.60.
Perrigo Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Friday, November 29th will be issued a dividend of $0.276 per share. The ex-dividend date of this dividend is Friday, November 29th. This represents a $1.10 dividend on an annualized basis and a dividend yield of 3.93%. Perrigo’s dividend payout ratio is currently -94.02%.
Wall Street Analyst Weigh In
A number of brokerages have weighed in on PRGO. Jefferies Financial Group restated a “hold” rating and issued a $30.00 price objective (down previously from $50.00) on shares of Perrigo in a report on Monday, September 23rd. Canaccord Genuity Group reissued a “buy” rating and issued a $42.00 price target on shares of Perrigo in a research note on Monday, September 30th. Finally, StockNews.com upgraded shares of Perrigo from a “hold” rating to a “buy” rating in a research report on Thursday, November 7th. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $37.00.
Check Out Our Latest Report on Perrigo
Insider Activity
In related news, Director Katherine C. Doyle sold 8,954 shares of the firm’s stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $27.30, for a total transaction of $244,444.20. Following the completion of the sale, the director now directly owns 6,009 shares of the company’s stock, valued at approximately $164,045.70. This trade represents a 59.84 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.70% of the company’s stock.
Perrigo Profile
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
See Also
- Five stocks we like better than Perrigo
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Fast-Growing Companies That Are Still Undervalued
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Top Cybersecurity Stock Picks for 2025
- Technology Stocks Explained: Here’s What to Know About Tech
- Archer or Joby: Which Aviation Company Might Rise Fastest?
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.